Menu

Clinical Trials

 

AES Webinar thumbnail

Why Payer Perspectives Should Be on Your Radar Now–Even if Your Launch is Years Away

Shefali Shah, principal of market access consulting, Evidera, and John Rafa, senior director of market intelligence, Accelerated Enrollment Solutions (AES), write about payer/health technology perspectives and trial design, optimal approaches for incorporating feedback and more.

Read more...
 

Blog-PatientEngagement-Thumbnail-final

Patient Engagement in Clinical Trial Protocol Design and Recruitment Strategies

Kevin Marsh, executive director, commercial strategy and new product development, patient-centered research, Evidera, and Margaret Vernon, vice president, general manager, patient-centered research, Evidera, discuss trial design and strategies for success.

Read more...
 

Las Vegas Clinic Thumbnail

The Benefits of Glucose Clamp Procedures in Clinical Trials

Adalberto Barba Jr., director of clinical operations, early development, at PPD’s clinical pharmacology unit in Las Vegas, Nevada, discusses the site’s capabilities in glucose clamp studies.

Read more...
 

PatientAdvantage thumbnail

Our Enrollment Solutions: PatientAdvantage

A new way of thinking about clinical development and delivery

Read more...
 

A practical guide for IMP supply chain planning post-Brexit

A practical guide for IMP supply chain planning post-Brexit

Brian Brogan, senior logistics manager, provides guidance for clinical trial supply chain requirements post-Brexit and offers some practical solutions for affected U.K.-based life science companies.

Read more...
 

Eligibility criteria in clinical trials - image of patient in hospital bed

Eligibility criteria in clinical trials

Giovanni Monopoli, senior project manager, reflects on what he learned about the eligibility criteria at an American Society of Clinical Oncology (ASCO) conference presentation in 2017.

Read more...
 

Woman with cancer and child - The challenges of immuno-oncology combined clinical development, Part IV

The challenges of immuno-oncology combined clinical development, Part IV

In the final of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Calendar planning holidays - Managing clinical studies through European holidays

Managing clinical studies through European holidays

PPD® Biotech’s Samantha Hadfield, senior director of project management, Helen Dunlop, director of project management, and Rania Laguel, director of project management, provide suggestions on preparing your study for the summer holidays in Europe.

Read more...
 

Cancer patient The challenges of immuno-oncology combined clinical development, Part III

The challenges of immuno-oncology clinical development, Part III

In the third of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
 

Cancer patient with medical professional for the challenges of combination therapies in immuno-oncology clinical development

The challenges of immuno-oncology clinical development, Part II

In the second of a four-part series, Jai Balkissoon, vice president of global product development, writes about the challenges in developing immuno-oncology therapies in combination clinical trials.

Read more...
Contact Legal Notices Modern Slavery Transparency Statement Privacy Policy

© 2019 Pharmaceutical Product Development, LLC. All rights reserved.